NF-kappa B-mediated chemoresistance in breast cancer cells.
about
Preadministration of High-Dose Salicylates, Suppressors of NF- B Activation, May Increase the Chemosensitivity of Many Cancers: An Example of Proapoptotic Signal Modulation TherapyAnti-cancer activity of new designer hydrogen sulfide-donating hybridsMEK5/ERK5 pathway: the first fifteen yearsUp-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta 1. A critical role of p38/nuclear factor-kappa B signaling pathwayHydrogen sulfide-releasing naproxen suppresses colon cancer cell growth and inhibits NF-κB signalingNitrosylcobalamin potentiates the anti-neoplastic effects of chemotherapeutic agents via suppression of survival signalingDevelopment of cell-based high-throughput assays for the identification of inhibitors of receptor activator of nuclear factor-kappa B signaling.Natural products as targeted modulators of the nuclear factor-kappaB pathway.Antiestrogenic effects of the novel sphingosine kinase-2 inhibitor ABC294640Targeting NFĸB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2Obesity and breast cancer: the roles of peroxisome proliferator-activated receptor-γ and plasminogen activator inhibitor-1Elevated expression of long intergenic non-coding RNA HOTAIR in a basal-like variant of MCF-7 breast cancer cells.BAG-1 interacts with the p50-p50 homodimeric NF-κB complex: implications for colorectal carcinogenesisElevated NIBP/TRAPPC9 mediates tumorigenesis of cancer cells through NFκB signalingProtective effect of caffeic acid on paclitaxel induced anti-proliferation and apoptosis of lung cancer cells involves NF-κB pathway.LDOC1 inhibits proliferation and promotes apoptosis by repressing NF-κB activation in papillary thyroid carcinomaPlatelets increase survival of adenocarcinoma cells challenged with anticancer drugs: mechanisms and implications for chemoresistance.Inhibition of p38 mitogen-activated protein kinase alters microRNA expression and reverses epithelial-to-mesenchymal transition.Sphingolipids as determinants of apoptosis and chemoresistance in the MCF-7 cell model system.Overexpressed nuclear BAG-1 in human hepatocellular carcinoma is associated with poor prognosis and resistance to doxorubicin.MEK kinase 1 induces mitochondrial permeability transition leading to apoptosis independent of cytochrome c release.The oncogenic Golgi phosphoprotein 3 like overexpression is associated with cisplatin resistance in ovarian carcinoma and activating the NF-κB signaling pathway.NFκBP65 transcription factor modulates resistance to doxorubicin through ABC transporters in breast cancer.
P2860
Q22299231-D27FC266-BB71-4A52-A240-76994B583B98Q26825705-F3FE7242-5EF9-4870-9BA0-92A56885D9A3Q26866383-4B5DA5C5-12D3-4C93-A0FF-7AF2907722A1Q28216853-568D5FAF-C0C8-42EA-B71C-8B0DDFC21E56Q28387183-2AD23DFA-E1BC-4E0E-9043-2A6E9E587625Q28471740-76D707BE-1D20-4C39-BFEE-2A868AF16429Q33738074-F3D56ADD-1BEE-4B90-ACC1-06269CA3B7A1Q34127458-31F43BC3-C509-46D0-8C7A-6013F7DD74F8Q34197851-7F7A8823-886A-49D3-95D7-57B1923EFC24Q34891145-4CA22D83-C941-4B99-8E8C-478AEA802B47Q34996841-54DFB3E9-9D51-45CB-855F-98C148ABE862Q35470183-5325BD77-E8E9-4747-AB2A-486A011DDE31Q35737918-A42C4FD9-7AE0-467B-BA7F-5FFA0E629C3DQ35742493-3AACA7EC-E809-4E0E-94AC-64D9DC5DBE1EQ36057212-14F099A3-A4CE-4D89-8C3B-224EA7BB4E86Q36348701-5E6ACC8B-5E0D-48C3-88C0-E0730EADCCB3Q36619756-BBD549AB-51C6-4E18-99B3-E7C985A69BD4Q36755634-9B2F780F-F30B-4552-AF6C-7634AB72F8FEQ37527497-5B32536B-9074-460A-B083-0134B5A4EDA2Q39171907-16EDD6A5-A12B-4C15-A2F6-946FC042592AQ40760800-168FF7A9-FD2D-4F8B-864C-896AC101988BQ42278865-A44CA5A0-9E7D-44CA-BBB2-0847FA57C6E5Q51050262-FDBD215F-1DF5-441E-9A4F-94640A3FB4DB
P2860
NF-kappa B-mediated chemoresistance in breast cancer cells.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
NF-kappa B-mediated chemoresistance in breast cancer cells.
@en
NF-kappa B-mediated chemoresistance in breast cancer cells.
@nl
type
label
NF-kappa B-mediated chemoresistance in breast cancer cells.
@en
NF-kappa B-mediated chemoresistance in breast cancer cells.
@nl
prefLabel
NF-kappa B-mediated chemoresistance in breast cancer cells.
@en
NF-kappa B-mediated chemoresistance in breast cancer cells.
@nl
P2093
P356
P1433
P1476
NF-kappa B-mediated chemoresistance in breast cancer cells.
@en
P2093
P304
P356
10.1067/MSY.2001.115512
P407
P577
2001-08-01T00:00:00Z